Drugs-for-fungal-infections-anti-fungal

International Journal of Scientific Study (IJSS): May, 2020Superficial fungal infections are caused by dermatophytes, non-dermatophytic molds, and commensal yeasts. According to published literature, the global prevalence rate of superficial mycotic infection has been found to be 20–25%. The recent prevalence of dermatophytosis in India ranges f...
JAMA Dermatology: Published November, 2022Despite the widespread use of nutritional supplements and dietary interventions for treating hair loss, the safety and effectiveness of available products remain unclear.The aim of the study is to evaluate and compile the findings of all dietary and nutritional interventions for treatment of hair loss a...
Pityriasis versicolor (PV) also known as tinea versicolor, which is chronic and superficial fungal skin disease caused by Malassezia yeasts. A permanent cure may difficult to achieve and this may explain the long-term nature of the disease. Consequently, a preventive treatment regimen may help to prevent the recurrence of pityriasis versicolor....
The British Journal of DermatologyDermatophytic infections have undergone unprecedented changes in India in the recent past. Oral antifungal drugs are considered to have a high cure rate in tinea corporis, tinea cruris and tinea faciei.Clinical trials to find out the effectiveness of the four main oral antifungal drugs are lacking.Authors teste...
Superficial fungal infections are primarily caused by dermatophytes, Candida spp, and Malassezia species affects 20%–25% of the world’s population.The lesion of dermatophytosis is present with an annular or ring-shaped red scaly plaque with central clearing, often associated with severe pruritus.Systemic or topical antifungal drugs are used as...
Clinicians should be more judicious in prescribing or recommending oral or topical antifungal therapy.Given the limited selection of antifungals, it is paramount to mitigate resistant cases. Mitigation proposals include:·              good skin hygiene,·    &nb...
International Journal of Research in Dermatology: Published on February, 2021Dermatophytic infections are the most prevalent fungal infections, which affect majority of the global population. Indian climate, especially the hot and humid conditions contribute majorly to dermatophytosis. Azoles are the most commonly used antifungal agents due  t...
Pityriasis versicolor (PV), also known as tinea versicolor, is caused by Malassezia species. This condition is one of the most common superficial fungal infections worldwide. This may be triggered by various factors, including humidity and high temperature, hyperhidrosis, familial susceptibility, and immunosuppression. Consequently,...
Tinea (pityriasis) versicolor is a superficial fungal infection and one of the most commonly found pigmentary disorders of skin caused by the yeast Malassezia. Multiple topical as well as systemic therapies are available for treatment. Systemic therapies are used for extensive disease, frequent relapse or where topical agents have failed. TAKE...
PubMed: Published on April 2022Seborrheic dermatitis (SD) is a common inflammatory skin disease, which is particularly prevalent in older adults, presenting with papulosquamous morphology in areas rich in sebaceous glands, particularly the scalp, face, and body folds.PathogenesisWhile a specific cause of seborrheic dermatitis remains largely un...
The Journal of Dermatology:Luliconazole Cream, 1% is an azole antifungal indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.TAKE HOME MESSAGES: Authors evaluated the efficacy and safety of luliconazole cream 1% in the treatmen...
European Academy of Dermatology and Venereology: Published on July, 2018Tinea capitis is the most common cutaneous fungal infection in children.TAKE HOME MESSAGEThis review aims to evaluate the differences that exist between medications for the treatment of tinea capitis, to determine whether there are any significant adverse effects associated...